Table 2. List of drugs approved by FDA for lung cancer therapy.

FDA: Food and Drug Administration.

Types of Agents	Name of Drug/Medicine	References
Chemotherapeutic agents	Doxorubicin	[3,4,22]
	Methotrexate	[22,23]
	Etoposide phosphate	[4,24]
	Mechlorethamine	[24,25]
	Topotecan	[26]
	Albumin-stabilized nanoparticle formulation of paclitaxel	[3,27]
	Carboplatin	[28]
	Atezolizumab with nab-paclitaxel and carboplatin	[29]
	Nivolumab	[30]
	Docetaxel	[31]
	Ramucirumab	[32]
	Capmatinib	[33]
	Gemcitabine	[34]
	Mechlorethamine	[24,25]
	Methotrexate	[22,23]
	Paclitaxel	[35]
	Pemetrexed disodium	[36]
	Vinorelbine tartrate	[37]
Biologically targeted therapeutic agents	Everolimus	[38]
	Afatinib	[39]
	Alectinib	[40]
	Brigatinib	[41]
	Ceritinib	[42]
	Crizotinib	[43]
	Dacomitinib	[44]
	Entrectinib	[45]
	Erlotinib HCl	[46,47]
	Gefitinib	[48,49]
	Osimertinib mesylate	[50,51]
	Trametinib	[52]
Immunotherapeutic agents	Atezolizumab	[53]
	Pembrolizumab	[54,55]
	Nivolumab	[56]
	Bevacizumab	[57,58]
	Durvalumab	[59]
	Necitumumab	[60]
	Ramucirumab	[61]